Publications

Links to NPCA peer-reviewed publications covering important topics in more depth.

The NPCA are involved in the ongoing publication of high-quality peer-reviewed articles. New publications will be announced via this website and Twitter.

 

Parry MG, Nossiter J, Cowling TE, Sujenthiran A, Berry B, Cathcart PJ, Clarke NW, Payne H and van der Meulen J, Aggarwal A. Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study. Radiotherapy and Oncology. 2021; 155: 48-55.

Access here

Parry MG, Nossiter J, Cowling TE, Sujenthiran A, Berry B, Cathcart PJ, Clarke NW, Payne H and van der Meulen J, Aggarwal A. Toxicity of pelvic lymph node irradiation with intensity modulated radiation therapy for high-risk and locally advanced prostate cancer: a national population-based study using patient-reported outcomes. International Journal of Radiation Oncology* Biology* Physics. 2020; Jul 24

Access here

Parry MG, Cowling TE, Sujenthiran A, Nossiter J, Berry B, Cathcart PJ, Aggarwal A, Payne H, van der Meulen J, Clarke NW and Gnanapragasam VJ. Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation. BMC Medicine. 2020; 18(1):1-9.

Access here

Berry B, Parry MG, Sujenthiran A, Nossiter J, Cowling TE, Aggarwal A, Cathcart PJ, Payne H, van der Meulen J, Clarke NW. Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study. BJU international. 2020; 126(1):97-103.

Access here

Nossiter J, Sujenthiran A, Cowling TE, Parry MG, Charman SC, Cathcart PJ, Clarke NW, Payne H, van der Meulen J, Aggarwal A. Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England. J Clin Oncol. 2020; 38(7):744-752.

Access here

Sujenthiran A, Parry MG, Nossiter J, Berry B, Cathcart PJ, Clarke NW, Payne H, van der Meulen J, Aggarwal A. Comparison of treatment-related toxicity with hypofractionated or conventionally fractionated radiation therapy for prostate cancer: a national population-based study. Clinical Oncology. 2020; 32(8):501-508.

Access here

Parry MG, Sujenthiran A, Cowling TE, Nossiter J, Berry B, Cathcart PJ, Clarke, NW, Payne H, Aggarwal A and van der Meulen J. Identifying skeletal-related events for prostate cancer patients in routinely collected hospital data. Cancer Epidemiology. 2019; 63: 101628.

Access here

Parry MG, Sujenthiran A, Cowling TE, Nossiter, J, Cathcart PJ, Clarke NW, Payne H, van der Meulen J and Aggarwal A. Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based Study. J Clin Oncol. 2019; 37(21):1828-1835

Access here

Parry MG, Sujenthiran A, Cowling TE, Nossiter J, Cathcart PJ, Clarke NW, Payne H, Aggarwal A, van der Meulen J. Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England. Int J Cancer. 2019; 145(1):40-48.

Access here

Parry MG, Sujenthiran A, Cowling TE, Charman SC, Nossiter J, Aggarwal A, Clarke NW, Payne H and van der Meulen J. Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions. Cancer Epidemiol. 2019; 58:44-51.

Access here

Nossiter J, Sujenthiran A, Charman SC, Cathcart PJ, Aggarwal, A, Payne, H, Clarke, NW and van der Meulen, J. Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England. British Journal of Cancer. 2018; 118(4):489-494.

Access here

Sujenthiran A, Nossiter J, Parry MG, Charman SC, Cathcart PJ, van der Meulen J, Clarke NW, Payne H and Aggarwal A. Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study. Radiotherapy and Oncology. 2018; 128(2):357-363.

Access here

Sujenthiran A, Nossiter J, Parry, MG, Charman SC, Aggarwal A, Payne H, Dasgupta P, Clarke NW, van der Meulen J and Cathcart PJ. National cohort study comparing severe medium-term urinary complications following radical prostatectomy: robot-assisted versus laparoscopic versus retropubic open radical prostatectomy. BJU international. 2017; 121(3):445-452.

Access here

Sujenthiran A, Nossiter J, Charman SC, Parry MG, Dasgupta P, van der Meulen J, Cathcart PJ, Clarke NW, Payne H and Aggarwal A. National population-based study comparing treatment-related toxicity in men who received intensity modulated versus 3-dimensional conformal radical radiation therapy for prostate cancer. International Journal of Radiation Oncology* Biology* Physics. 2017; 99(5): 1253-1260.

Access here

Sujenthiran A, Charman SC, Parry M, Nossiter J, Aggarwal A, Dasgupta P, Payne H, Clarke NW, Cathcart P and van der Meulen J. Quantifying severe urinary complications after radical prostatectomy: the development and validation of a surgical performance indicator using hospital administrative data. BJU international. 2017; 120(2): 219-225.

Access here

Aggarwal A, Nossiter J, Cathcart PJ, Rashbass J, Payne H and van der Meulen J. The National Prostate Cancer Audit–results from the organisational survey of NHS Trusts in England. Clinical Oncology. 2017; 27(3): 482-9.

Access here

Aggarwal A, Cathcart PJ, Payne H, Neal DE, Rashbass J, Nossiter J and van der Meulen J. The National Prostate Cancer Audit—introducing a new generation of cancer audit. Clinical Oncology. 2017; 26(2):90-3.

Access here

Cathcart P, Nossiter J, Aggarwal A, Rashbass J, Lyratzopoulos Y, Payne H, Neal DE and van der Meulen J. The first national clinical audit of prostate cancer care. BJU international. 2013;112(7):883-4.

Access here

Last updated: 9 November 2020, 12:49pm